Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Chronic Myelogenous Leukemia Treatment
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.4 Billion by ... Read More
-
Cancer Cachexia
... CAGR of 5.7% over the analysis period 2024-2030. Progestogens, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Breast Cancer Therapeutics
... at a CAGR of 12.3% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by the end of ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More
-
Cancer Care (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Cancer Care (UK) report will tell you the companies that have ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Refractory Metastatic Melanoma: ... Read More
-
2025 Global Gene Therapy For Cancer Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030
... the increasing volume and complexity of global clinical trials, the rise of personalized medicine, and stringent regulatory requirements. Decentralized and adaptive trial designs are fueling demand for specialized supply chain solutions, including direct-to-patient logistics and ... Read More
-
Global Oncology Drugs Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Virtual Oncology Market, By Component (Software, Service, Hardware), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Others (Pancreatic, Ovarian, etc.)), By Application (Precision Medicine, Patient Care Management, Research & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others (Reference Laboratories, Pharmacies etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience. With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained ... Read More
-
Squamous Non-Small Cell Lung Cancer - Global Clinical Trials Review, 2025
... Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, and Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to the increasing applications ... Read More
-
Fecal Calprotectin Test Market, By Assay Type (Enzyme Linked Immunosorbent Assay (ELISA), Enzyme Fluoroimmunoassay, and Quantitative Immune-Chromatography), By Indication (Inflammatory Bowel Disease (IBD) Diagnosis, Colorectal Cancer, Celiac Disease, and others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and others), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... making it a helpful biomarker for identifying and tracking the condition. Market Dynamics: The increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing are anticipated to drive growth of ... Read More
-
Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagno
... tailor treatment based on an individual’s genetic profile and select therapeutics that directly target the abnormalities present. The genomic analysis of a tumor helps predict response to certain drugs, checks for genetic markers that may ... Read More
-
Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030
... CAGR due to rising R&D investments of pharmaceutical and biopharmaceutical firms. As the pipeline of R&D expands, the requirement for outsourcing analytical testing is set to rise, in addition to the research initiatives on the ... Read More
-
Global Cancer Biologics Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions
... of development and its mechanisms of metastasis and recurrence. It also incorporates the disease burden by knowing the epidemiology of different cancers. Treatment patterns that include both non-pharmacological (e.g., radiation, surgery) and pharmacological (e.g., hormonal ... Read More
-
Oncology Precision Medicine Market by Type of Cancer Targeted
... CAGR of 8.5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Cancer Targeted Bladder Cancer Blood / Hematologic Cancer Breast Cancer Cervical ... Read More
-
Cancer Biomarkers Market by Type of Biomarker
... 5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Biomarker HER2 MET EGFR PD-L1 NTRK ALK Novel Biomarkers Other Biomarkers Type of ... Read More
-
2025 Austria Diagnostics Market Shares and Segment Forecasts 500 Tests: 2024 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endoc
... Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM The report profiles over 70 companies, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Cepheid/Danaher ... Read More
-
2025 Bulgaria Diagnostics Market Shares and Segment Forecasts 500 Tests: 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine
... Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM The report profiles over 70 companies, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Cepheid/Danaher ... Read More
-
2025 United Kingdom Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS CAN1310 Read More
-
2025 Japan Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS CAN1310 Read More
-
2025 China Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS CAN1310 Read More
Research Assistance
